Doctor Espresso Limited 06171278 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is that of coffee outlets. Digita Accounts Production Advanced 6.30.9574.0 true true 06171278 2024-04-01 2025-03-31 06171278 2025-03-31 06171278 bus:OrdinaryShareClass1 2025-03-31 06171278 core:CurrentFinancialInstruments 2025-03-31 06171278 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 06171278 core:Non-currentFinancialInstruments 2025-03-31 06171278 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 06171278 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-03-31 06171278 core:Goodwill 2025-03-31 06171278 core:FurnitureFittingsToolsEquipment 2025-03-31 06171278 core:LandBuildings 2025-03-31 06171278 core:MotorVehicles 2025-03-31 06171278 core:OtherPropertyPlantEquipment 2025-03-31 06171278 bus:SmallEntities 2024-04-01 2025-03-31 06171278 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 06171278 bus:FilletedAccounts 2024-04-01 2025-03-31 06171278 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 06171278 bus:RegisteredOffice 2024-04-01 2025-03-31 06171278 bus:Director1 2024-04-01 2025-03-31 06171278 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 06171278 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 06171278 bus:Agent1 2024-04-01 2025-03-31 06171278 core:ComputerSoftware 2024-04-01 2025-03-31 06171278 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-04-01 2025-03-31 06171278 core:Goodwill 2024-04-01 2025-03-31 06171278 core:FurnitureFittings 2024-04-01 2025-03-31 06171278 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 06171278 core:LandBuildings 2024-04-01 2025-03-31 06171278 core:LeaseholdImprovements 2024-04-01 2025-03-31 06171278 core:MotorVehicles 2024-04-01 2025-03-31 06171278 core:OfficeEquipment 2024-04-01 2025-03-31 06171278 core:OtherPropertyPlantEquipment 2024-04-01 2025-03-31 06171278 core:PlantMachinery 2024-04-01 2025-03-31 06171278 core:OtherRelatedParties 2024-04-01 2025-03-31 06171278 countries:AllCountries 2024-04-01 2025-03-31 06171278 2024-03-31 06171278 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-03-31 06171278 core:Goodwill 2024-03-31 06171278 core:FurnitureFittingsToolsEquipment 2024-03-31 06171278 core:LandBuildings 2024-03-31 06171278 core:MotorVehicles 2024-03-31 06171278 core:OtherPropertyPlantEquipment 2024-03-31 06171278 2023-04-01 2024-03-31 06171278 2024-03-31 06171278 bus:OrdinaryShareClass1 2024-03-31 06171278 core:CurrentFinancialInstruments 2024-03-31 06171278 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 06171278 core:Non-currentFinancialInstruments 2024-03-31 06171278 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 06171278 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-03-31 06171278 core:Goodwill 2024-03-31 06171278 core:FurnitureFittingsToolsEquipment 2024-03-31 06171278 core:LandBuildings 2024-03-31 06171278 core:MotorVehicles 2024-03-31 06171278 core:OtherPropertyPlantEquipment 2024-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 06171278

Doctor Espresso Limited
Unaudited Filleted Financial Statements
for the Year Ended 31 March 2025

Doctor Espresso Limited

Contents

Company Information | 1
Balance Sheet | 2 to 3
Notes to the Unaudited Financial Statements | 4 to 11

Doctor Espresso Limited

Company Information

Director | Ms Vanessa Lancellotti

Registered office | 88 Peterborough Road London SW6 3HH

Accountants | Michaelides Warner & Co 102 Fulham Palace Road London W6 9PL

Doctor Espresso Limited

(Registration number: 06171278)
Balance Sheet as at 31 March 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Intangible assets | 4 | 4,824 | 6,600
Tangible assets | 5 | 10,050 | 12,151
|  | 14,874 | 18,751
Current assets |  |  |
Stocks | 6 | 6,741 | 3,235
Debtors | 7 | 131,825 | 88,414
Cash at bank and in hand |  | 27,566 | 44,682
|  | 166,132 | 136,331
Creditors: Amounts falling due within one year | 8 | (206,407) | (150,951)
Net current liabilities |  | (40,275) | (14,620)
Total assets less current liabilities |  | (25,401) | 4,131
Creditors: Amounts falling due after more than one year | 8 | (29,154) | (31,854)
Net liabilities |  | (54,555) | (27,723)
Capital and reserves |  |  |
Called up share capital | 9 | 2 | 2
Retained earnings |  | (54,557) | (27,725)
Shareholders' deficit |  | (54,555) | (27,723)

Doctor Espresso Limited

(Registration number: 06171278)
Balance Sheet as at 31 March 2025

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director 's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 ; and
• | The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 12 March 2026

Ms Vanessa Lancellotti Director |  |

Doctor Espresso Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales .

The address of its registered office is:
88 Peterborough Road
London
SW6 3HH
England

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Judgements

The director considers that there are no key judgements that management have made in the process of applying the company's accounting policies and that may have had a significant effect on the amounts recognised in the financial statements.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when the amount of revenue can be reliably measured, it is probable that future economic benefits will flow to the entity and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

Doctor Espresso Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Motor vehicles | 25% Reducing balance
Fixtures and fittings | 25% Reducing balance, and straight line method
Plant and machinery | 25% Reducing balance, and straight line method
Office equipment | 25% Straight line
Leasehold improvements | Straight line over 20 years

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class | Amortisation method and rate
Website domain | 12.5% Straight line
Goodwill | 10% Straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Doctor Espresso Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.
The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.
Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.
Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Doctor Espresso Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Financial instruments

Classification
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like investments, trade and other receivables,cash and bank balances, trade and other creditors.
Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or cash consolidation expected to be paid or received.

3 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 11 (2024 - 13).

4 | Intangible assets

| Goodwill £ | Internally generated software development costs £ | Total £
Cost or valuation
At 1 April 2024 | 8,040 | 120 | 8,160
At 31 March 2025 | 8,040 | 120 | 8,160
Amortisation
At 1 April 2024 | 1,440 | 120 | 1,560
Amortisation charge | 1,776 | - | 1,776
At 31 March 2025 | 3,216 | 120 | 3,336
Carrying amount
At 31 March 2025 | 4,824 | - | 4,824
At 31 March 2024 | 6,600 | - | 6,600

Doctor Espresso Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

5 | Tangible assets

| Land and buildings £ | Furniture, fittings and equipment £ | Motor vehicles £ | Other tangible assets £
Cost or valuation
At 1 April 2024 | 20,000 | 1,952 | 1,200 | 9,473
At 31 March 2025 | 20,000 | 1,952 | 1,200 | 9,473
Depreciation
At 1 April 2024 | 11,000 | 1,665 | 1,200 | 6,609
Charge for the year | 1,000 | 144 | - | 957
At 31 March 2025 | 12,000 | 1,809 | 1,200 | 7,566
Carrying amount
At 31 March 2025 | 8,000 | 143 | - | 1,907
At 31 March 2024 | 9,000 | 287 | - | 2,864

| Total £
Cost or valuation
At 1 April 2024 | 32,625
At 31 March 2025 | 32,625
Depreciation
At 1 April 2024 | 20,474
Charge for the year | 2,101
At 31 March 2025 | 22,575
Carrying amount
At 31 March 2025 | 10,050
At 31 March 2024 | 12,151

Included within the net book value of land and buildings above is £8,000 (2024 - £9,000) in respect of short leasehold land and buildings.

Doctor Espresso Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

6 | Stocks

| 2025 £ | 2024 £
Other inventories | 6,741 | 3,235

7 | Debtors

| 2025 £ | 2024 £
Trade debtors | 543 | 446
Prepayments | 9,622 | 11,245
Other debtors | 121,660 | 76,723
| 131,825 | 88,414

Doctor Espresso Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

8 | Creditors

Creditors: amounts falling due within one year

| Note | 2025 £ | 2024 £
Due within one year |  |  |
Loans and borrowings | 10 | 31,340 | 16,913
Trade creditors |  | 57,596 | 45,795
Taxation and social security |  | 35,250 | 15,502
Accruals and deferred income |  | 1,600 | 1,600
Other creditors |  | 80,621 | 71,141
|  | 206,407 | 150,951

Creditors: amounts falling due after more than one year

| Note | 2025 £ | 2024 £
Due after one year |  |  |
Loans and borrowings | 10 | 29,154 | 31,854

9 | Share capital

Allotted, called up and fully paid shares

| 2025 | 2024
| No. | £ | No. | £
Ordinary shares of £1 each | 2 | 2 | 2 | 2

10 | Loans and borrowings

Non-current loans and borrowings

| 2025 £ | 2024 £
Bank borrowings | 29,154 | 31,854

Doctor Espresso Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Current loans and borrowings

| 2025 £ | 2024 £
Bank borrowings | 4,595 | 6,219
Bank overdrafts | 26,745 | 10,694
| 31,340 | 16,913

11 | Related party transactions

Summary of transactions with other related parties

There is an amount owed to the Director of £44,977 (2024:£39,442)
Included in other debtors is a loan of £109,273 (2024: £64,335) owed by Doctor R Espresso Limited